TFEB and neurodegenerative disease: Moreover, by using the SH-SY5Y neuroblastoma cell line, we confirmed the ability of the curcumin analogue C1 to activate TFEB without inhibiting mTORC1 activity, thus suggesting its potential therapeutic efficacy for the treatment of neurodegenerative diseases by promoting autophagy.